15:52 Dec 05

Ind-Swift Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
95.90
+2.72 (+2.92%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Ind-Swift Laboratories Ltd. Financials

Ind-Swift Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
95.90
+2.72 (+2.92%)
15:52 Dec 05
Quality
image/svg+xml

41/100
Medium Financial Strength

Valuation
image/svg+xml

40/100
Mid Valuation

Technical

43/100
Technically Neutral

Strength

6

Weakness

10

Opportunity

1

Threats

0

19.06 %

ROE %

15.54 %

ROA %

29.29

EPS

170.63

BVPS

116.45 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1038.73 1207.31 1280.9 192.02 452.27
Operating Expenses +
842.35 978.11 1026.7 237.28 470.91
Raw Material
566.06 667.92 624.39 92.01 208.43
Increase Decrease in Cost
-39.47 -12.34 37.07 7.54 6.22
Other Manufacturing Expense
84.14 111.28 100.68 0 0
Employee Cost
114.35 135.84 152.81 49.91 106.82
Miscellaneous Expenses
119.39 96.33 162.41 207.74 149.44
Operating Profit
196.38 229.2 254.2 -45.26 -18.64
Other Income
42.71 33.5 45.37 42.42 50.71
Depreciation
131.04 57.36 53.3 8.15 21.35
Interest
95.53 92.17 51.1 -26.06 -23.49
Profit before tax and exceptio..
12.53 113.17 195.17 15.07 34.21
Exceptional Items
0 -26.65 386.59 215.88 215.88
PBT
12.53 86.52 581.76 230.95 -181.67
Provision for Taxation
14.68 38.69 160.31 7.27 11.12
Net Profit
-2.15 47.83 421.45 223.68 238.95
NET Profit after MI
-2.15 47.6 420.96 223.62 239.04
EPS
-0.36 8.1 71.24 32.53 35.24
Operating Profit Margin (%)
18.91 18.98 19.85 -23.57 -4.12
Net Profit Margin (%)
-0.21 3.94 32.86 116.46 52.85

Ind-Swift Laboratories Ltd. Shareholding

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 39.50 40.90 40.90 42.00 42.00 42.00
FII 14.80 4.30 3.10 0.50 0.60 1.30
Public 0.70 0.90 0.90 0.90 1.00 0.90
Others 45.00 53.90 55.10 56.60 56.40 55.80
Shareholder Shares Holding %
Download Our App On: